BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2532099)

  • 1. Xiaoke tea, a Chinese herbal treatment for diabetes mellitus.
    Hale PJ; Horrocks PM; Wright AD; Fitzgerald MG; Nattrass M; Bailey CJ
    Diabet Med; 1989 Nov; 6(8):675-6. PubMed ID: 2532099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xiaoke, a traditional Chinese treatment for diabetes. Studies in streptozotocin diabetic mice and spontaneously diabetic BB/E rats.
    Bailey CJ; Brown D; Smith W; Bone AJ
    Diabetes Res; 1987 Jan; 4(1):15-8. PubMed ID: 3552362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved postprandial glycaemic control with insulin Aspart in type 2 diabetic patients treated with insulin.
    Rosenfalck AM; Thorsby P; Kjems L; Birkeland K; Dejgaard A; Hanssen KF; Madsbad S
    Acta Diabetol; 2000 Mar; 37(1):41-6. PubMed ID: 10928235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety.
    Vuksan V; Sung MK; Sievenpiper JL; Stavro PM; Jenkins AL; Di Buono M; Lee KS; Leiter LA; Nam KY; Arnason JT; Choi M; Naeem A
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):46-56. PubMed ID: 16860976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Meilian Xiaoke capsule combined with metformin for protecting islet cells and lowering blood glucose in diabetic rats].
    Hu C; Zhang S; Jin X; Tong L
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Aug; 34(9):1365-9. PubMed ID: 25263377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism.
    Osei K; O'Dorisio TM; Falko JM
    Am J Med; 1984 Dec; 77(6):1002-9. PubMed ID: 6439036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized and double-blinded pilot clinical study of the safety and anti-diabetic efficacy of the Rauvolfia-Citrus tea, as used in Nigerian traditional medicine.
    Campbell-Tofte JI; Mølgaard P; Josefsen K; Abdallah Z; Hansen SH; Cornett C; Mu H; Richter EA; Petersen HW; Nørregaard JC; Winther K
    J Ethnopharmacol; 2011 Jan; 133(2):402-11. PubMed ID: 20955771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities.
    Fukino Y; Ikeda A; Maruyama K; Aoki N; Okubo T; Iso H
    Eur J Clin Nutr; 2008 Aug; 62(8):953-60. PubMed ID: 17554248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus?
    Scott R; Lintott CJ; Zimmet P; Campbell L; Bowen K; Welborn T
    Diabetes Res Clin Pract; 1999 Mar; 43(3):179-85. PubMed ID: 10369427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise Combined with a Chinese Medicine Herbal Tea for Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
    Zhang J; Liu M; Hu B; Wang L
    J Integr Complement Med; 2022 Nov; 28(11):878-886. PubMed ID: 36037014
    [No Abstract]   [Full Text] [Related]  

  • 11. The safety and effectiveness of TM81, a Chinese herbal medicine, in the treatment of type 2 diabetes: a randomized double-blind placebo-controlled trial.
    Tong XL; Wu ST; Lian FM; Zhao M; Zhou SP; Chen XY; Yu B; Zhen Z; Qi LW; Li P; Wang CZ; Sun H; Yuan CS
    Diabetes Obes Metab; 2013 May; 15(5):448-54. PubMed ID: 23231379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetic effect of Gynostemma pentaphyllum tea in randomly assigned type 2 diabetic patients.
    Huyen VT; Phan DV; Thang P; Hoa NK; Ostenson CG
    Horm Metab Res; 2010 May; 42(5):353-7. PubMed ID: 20213586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the carbohydrase inhibitor miglitol in sulfonylurea-treated NIDDM patients.
    Johnston PS; Coniff RF; Hoogwerf BJ; Santiago JV; Pi-Sunyer FX; Krol A
    Diabetes Care; 1994 Jan; 17(1):20-9. PubMed ID: 8112185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of glycosylated hemoglobin and postprandial hyperglycemia by acarbose in patients with NIDDM. A placebo-controlled dose-comparison study.
    Coniff RF; Shapiro JA; Robbins D; Kleinfield R; Seaton TB; Beisswenger P; McGill JB
    Diabetes Care; 1995 Jun; 18(6):817-24. PubMed ID: 7555508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-diabetic effects of TongGuanWan, a Chinese traditional herbal formula, in C57BL/KsJ-db/db mice.
    Tang YH; Sun ZL; Fan MS; Li ZX; Huang CG
    Planta Med; 2012 Jan; 78(1):18-23. PubMed ID: 22002851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combined treatment of type-2 diabetics with insulin and glibenclamide after secondary drug failure. Double-blind, insulin-placebo-controlled crossover study].
    Rosak C; Schwarz O; Althoff PH; Schöffling K; Schmidt FH
    Dtsch Med Wochenschr; 1985 Dec; 110(51-52):1975-80. PubMed ID: 3935405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study.
    Mackenzie T; Leary L; Brooks WB
    Metabolism; 2007 Oct; 56(10):1340-4. PubMed ID: 17884442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166).
    Gribble FM; Manley SE; Levy JC
    Diabetes Care; 2001 Jul; 24(7):1221-5. PubMed ID: 11423506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humalog Mix50 before carbohydrate-rich meals in type 2 diabetes mellitus.
    Roach P; Arora V; Campaigne BN; Mattoo V; Rangwala S;
    Diabetes Obes Metab; 2003 Sep; 5(5):311-6. PubMed ID: 12940868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.
    Schwartz S; Raskin P; Fonseca V; Graveline JF
    N Engl J Med; 1998 Mar; 338(13):861-6. PubMed ID: 9516220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.